Russian Oncological Research Center n.a. N.N.Blokhin of MoH (Site 1100)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Endometrial cancer

Closed trials

• Completed

  Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001)

  NCT03884101· Phase 3· Merck Sharp & Dohme LLC· Source